New drug tested for tough transplant complication
NCT ID NCT03604692
Summary
This study tested an experimental drug called axatilimab for people with chronic graft-versus-host disease (cGVHD) that hadn't improved after at least two previous treatments. The trial aimed to find a safe dose and see if the drug could help control the disease. It involved 41 participants and was designed to measure how their bodies responded to the treatment and whether their symptoms improved.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC GRAFT VERSUS HOST DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope
Duarte, California, 91010, United States
-
Fred Hutchinson Cancer Research Center
Seattle, Washington, 98109, United States
-
Indiana University Health Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, 46202, United States
-
Karmanos Cancer Institute
Detroit, Michigan, 48201, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
-
University of Miami Miller School of Medicine
Miami, Florida, 33136, United States
-
University of Minnesota Medical Center
Minneapolis, Minnesota, 55455, United States
-
University of Utah Health Huntsman Cancer Institute
Salt Lake City, Utah, 84112, United States
-
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, 37212-3505, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.